Cargando…
Human Breast Tumor Cells Are More Resistant to Cardiac Glycoside Toxicity Than Non-Tumorigenic Breast Cells
Cardiotonic steroids (CTS), specific inhibitors of Na,K-ATPase activity, have been widely used for treating cardiac insufficiency. Recent studies suggest that low levels of endogenous CTS do not inhibit Na,K-ATPase activity but play a role in regulating blood pressure, inducing cellular kinase activ...
Autores principales: | Clifford, Rebecca J., Kaplan, Jack H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862803/ https://www.ncbi.nlm.nih.gov/pubmed/24349570 http://dx.doi.org/10.1371/journal.pone.0084306 |
Ejemplares similares
-
The role of cardiac glycosides in influencing breast cancer cell proliferation
por: Quinlan, KD, et al.
Publicado: (2012) -
Inflammasome inhibition blocks cardiac glycoside cell toxicity
por: LaRock, Doris L., et al.
Publicado: (2019) -
FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells
por: Kim, Sungeun, et al.
Publicado: (2013) -
Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
por: Ozawa, Patricia Midori Murobushi, et al.
Publicado: (2018) -
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)